Preventing suicide and self-harm: a global challenge too far?
Date and time
Location
Online event
Suicide and self-harm are intensely individual experiences but ones which occur in a global context. Is prevention at scale even possible?
About this event
Join our expert panel of researchers, clinicians, and people with lived experience to hear about the recent Lancet Seminar on suicide and self-harm, and discuss how far we’ve come, and how far we still need to go.
This is the paper we will be discussing: Knipe D, Padmanathan P, Newton-Howes G, Chan LF, Kapur N. (2022) Suicide and self-harm. The Lancet, 2022 https://doi.org/10.1016/S0140-6736(22)00173-8
Panel
- Dr Dee Knipe, EBI Vice Chancellor's Fellow, Bristol Medical School, UK
- Prof Nav Kapur, Head of Suicide Research, Professor of Psychiatry and Population Health, University of Manchester, UK
- Tanmoy Goswami, User-survivor and mental health journalist, India; Incoming fellow, Reuters Institute for the Study of Journalism, University of Oxford, UK
- Dr Jason Bantijes, Associate Professor in the Psychology Department at Stellenbosch University, South Africa.
Suicide and self-harm have emerged in recent years as important global challenges. Both have been the subject of much attention and even more speculation during the COVID-19 pandemic. They are unique a phenomena - intensely individual experiences occurring in a societal and global context. Suicide is sometimes wrongly seen as an inevitable outcome of despair with little role for clinicians or the wider public in prevention. Recently we have all become aware of how world events can influence our mental health. With this in mind, how do we prevent suicide deaths and stop people harming themselves, not just in high income countries but globally?
During this webinar we will be hearing about the latest research evidence from the recently published Lancet Seminar on Suicide and Self-Harm. We will also be discussing where we go from here with the authors of the paper and other experts. This webinar will be of interest to clinicians from any speciality as well as policymakers, researchers and those with lived experience.